MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Wang, Xiao ^a   Wu, Jian ^a   Lin, Yiwei ^a   Zhu, Yi ^a   Xu, Xianglai ^a   Xu, Xin ^a   Liang, Zhen ^a   Li, Shiqi ^a   Hu, Zhenghui ^a   Zheng, Xiangyi ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bladder cancer; CDK6; Invasion; Migration; miR 320c; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE 6; MICRORNA; MICRORNA 320C; UNCLASSIFIED DRUG; CDK6 PROTEIN, HUMAN; MIRN320 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE ASSAY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMATION; COLONY FORMING UNIT; COMPARATIVE STUDY; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; MIDDLE AGED; MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE BLADDER CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING; BLADDER TUMOR; CELL MOTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 6; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 84906960313     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-014-0069-6     Document Type: Article

References (36)

1. Global cancer statistics. A Jemal, F Bray, MM Center, J Ferlay, E Ward, D Forman, CA Cancer J Clin 2011 61 2 69 90 10.3322/caac.20107 21296855
2. Cancer statistics, 2014. R Siegel, J Ma, Z Zou, A Jemal, CA Cancer J Clin 2014 64 1 9 29 10.3322/caac.21208 24399786
3. A meta-analysis of tea consumption and the risk of bladder cancer. X Wang, YW Lin, S Wang, J Wu, QQ Mao, XY Zheng, LP Xie, Urol Int 2013 90 1 10 16 10.1159/000342804 23052791
4. NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guerin therapy for bladder cancer. E Chiong, A Kesavan, R Mahendran, YH Chan, JH Sng, YK Lim, R Kamaraj, TM Tan, K Esuvaranathan, Eur Urol 2011 59 3 430 437 10.1016/j.eururo.2010.11.031 21163569
5. DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach. V Casadio, C Molinari, D Calistri, M Tebaldi, R Gunelli, L Serra, F Falcini, C Zingaretti, R Silvestrini, D Amadori, W Zoli, J Exp Clin Cancer Res 2013 32 94 10.1186/1756-9966-32-94 24252461
6. MicroRNAs: genomics, biogenesis, mechanism, and function. DP Bartel, Cell 2004 116 2 281 297 10.1016/S0092-8674(04)00045-5 14744438
7. MicroRNAs: target recognition and regulatory functions. DP Bartel, Cell 2009 136 2 215 233 10.1016/j.cell.2009.01.002 19167326
8. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. GA Calin, CG Liu, C Sevignani, M Ferracin, N Felli, CD Dumitru, M Shimizu, A Cimmino, S Zupo, M Dono, ML Dell'Aquila, H Alder, L Rassenti, TJ Kipps, F Bullrich, M Negrini, CM Croce, Proc Natl Acad Sci U S A 2004 101 32 11755 11760 10.1073/pnas.0404432101 15284443
9. A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma. B Zhou, H Chen, D Wei, Y Kuang, X Zhao, G Li, J Xie, P Chen, J Exp Clin Cancer Res 2014 33 1 55 10.1186/1756-9966-33-55 24980149
10. miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. C Ma, K Nong, B Wu, B Dong, Y Bai, H Zhu, W Wang, X Huang, Z Yuan, K Ai, J Exp Clin Cancer Res 2014 33 54 10.1186/1756-9966-33-54 24961235
11. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. Z Wang, J Wang, Y Yang, B Hao, R Wang, Y Li, Q Wu, J Exp Clin Cancer Res 2013 32 76 10.1186/1756-9966-32-76 24422944
12. MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b. Y Li, Y Chao, Y Fang, J Wang, M Wang, H Zhang, M Ying, X Zhu, H Wang, J Exp Clin Cancer Res 2013 32 33 10.1186/1756-9966-32-33 23718732
13. Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. SM Gao, JJ Yang, CQ Chen, JJ Chen, LP Ye, LY Wang, JB Wu, CY Xing, K Yu, J Exp Clin Cancer Res 2012 31 27 10.1186/1756-9966-31-27 22449094
14. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. JW Catto, A Alcaraz, AS Bjartell, WR De Vere, CP Evans, S Fussel, FC Hamdy, O Kallioniemi, L Mengual, T Schlomm, T Visakorpi, Eur Urol 2011 59 5 671 681 10.1016/j.eururo.2011.01.044 21296484
15. Micro-RNA profiling in kidney and bladder cancers. F Gottardo, CG Liu, M Ferracin, GA Calin, M Fassan, P Bassi, C Sevignani, D Byrne, M Negrini, F Pagano, LG Gomella, CM Croce, R Baffa, Urol Oncol 2007 25 5 387 392 10.1016/j.urolonc.2007.01.019 17826655
16. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. LX Yan, XF Huang, Q Shao, MY Huang, L Deng, QL Wu, YX Zeng, JY Shao, RNA 2008 14 11 2348 2360 10.1261/rna.1034808 18812439
17. Diagnostic and prognostic microRNAs in stage II colon cancer. T Schepeler, JT Reinert, MS Ostenfeld, LL Christensen, AN Silahtaroglu, L Dyrskjot, C Wiuf, FJ Sorensen, M Kruhoffer, S Laurberg, S Kauppinen, TF Orntoft, CL Andersen, Cancer Res 2008 68 15 6416 6424 10.1158/0008-5472.CAN-07-6110 18676867
18. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. DG Schaar, DJ Medina, DF Moore, RK Strair, Y Ting, Exp Hematol 2009 37 2 245 255 10.1016/j.exphem.2008.10.002 19135902
19. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. IS Hsieh, KC Chang, YT Tsai, JY Ke, PJ Lu, KH Lee, SD Yeh, TM Hong, YL Chen, Carcinogenesis 2013 34 3 530 538 10.1093/carcin/bgs371 23188675
20. GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma. J Yao, LH Liang, Y Zhang, J Ding, Q Tian, JJ Li, XH He, Cancer Biol Med 2012 9 4 234 241 23691483
21. miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1. Y Iwagami, H Eguchi, H Nagano, H Akita, N Hama, H Wada, K Kawamoto, S Kobayashi, A Tomokuni, Y Tomimaru, M Mori, Y Doki, Br J Cancer 2013 109 2 502 511 10.1038/bjc.2013.320 23799850
22. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Y Zhu, Y Lu, Q Zhang, JJ Liu, TJ Li, JR Yang, C Zeng, SM Zhuang, Nucleic Acids Res 2012 40 10 4615 4625 10.1093/nar/gkr1278 22210897
23. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. X Chen, X Wang, A Ruan, W Han, Y Zhao, X Lu, P Xiao, H Shi, R Wang, L Chen, S Chen, Q Du, H Yang, X Zhang, Clin Cancer Res 2014 20 10 2617 2630 10.1158/1078-0432.CCR-13-3224 24647573
24. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. X Zhu, Y Li, H Shen, H Li, L Long, L Hui, W Xu, FEBS Lett 2013 587 1 73 81 10.1016/j.febslet.2012.11.004 23178712
25. A p18 mutant defective in CDK6 binding in human breast cancer cells. J Lapointe, Y Lachance, Y Labrie, C Labrie, Cancer Res 1996 56 20 4586 4589 8840966
26. Increased cyclin-dependent kinase 6 expression in bladder cancer. G Wang, L Zheng, Z Yu, G Liao, L Lu, R Xu, Z Zhao, G Chen, Oncol Lett 2012 4 1 43 46 22807957
27. Urothelial carcinoma of the bladder: definition, treatment and future efforts. SM Prasad, GJ Decastro, GD Steinberg, Nat Rev Urol 2011 8 11 631 642 10.1038/nrurol.2011.144 21989305
28. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. I Koturbash, FJ Zemp, I Pogribny, O Kovalchuk, Mutat Res 2011 722 2 94 105 10.1016/j.mrgentox.2010.05.006 20472093
29. miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4. M Zhang, Q Yang, L Zhang, S Zhou, W Ye, Q Yao, Z Li, C Huang, Q Wen, J Wang, J Exp Clin Cancer Res 2014 33 10 10.1186/1756-9966-33-10 24438167
30. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. N Yang, S Kaur, S Volinia, J Greshock, H Lassus, K Hasegawa, S Liang, A Leminen, S Deng, L Smith, CN Johnstone, XM Chen, CG Liu, Q Huang, D Katsaros, GA Calin, BL Weber, R Butzow, CM Croce, G Coukos, L Zhang, Cancer Res 2008 68 24 10307 10314 10.1158/0008-5472.CAN-08-1954 19074899
31. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. Y Lin, H Chen, Z Hu, Y Mao, X Xu, Y Zhu, J Wu, S Li, Q Mao, X Zheng, L Xie, FEBS Lett 2013 587 15 2467 2473 10.1016/j.febslet.2013.06.021 23796420
32. MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. S Li, X Xu, Z Hu, J Wu, Y Zhu, H Chen, Y Mao, Y Lin, J Luo, X Zheng, L Xie, Biochem Biophys Res Commun 2013 441 4 976 981 10.1016/j.bbrc.2013.11.006 24220339
33. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. MW Landis, BS Pawlyk, T Li, P Sicinski, PW Hinds, Cancer Cell 2006 9 1 13 22 10.1016/j.ccr.2005.12.019 16413468
34. Let-7a functions as a tumor suppressor in Ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6. Z Zhang, L Huang, Z Yu, X Chen, D Yang, P Zhan, M Dai, S Huang, Z Han, K Cao, DNA Cell Biol 2014 33 3 136 147 10.1089/dna.2013.2179 24383407
35. Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity. R Lamb, S Lehn, L Rogerson, RB Clarke, G Landberg, Cell Cycle 2013 12 15 2384 2394 10.4161/cc.25403 23839043
36. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. C Wang, MP Lisanti, DJ Liao, Cell Cycle 2011 10 1 57 67 10.4161/cc.10.1.14449 21200143